Rezolute, Inc. Common Stock (NV) (RZLT) is a publicly traded Healthcare sector company. As of September 24, 2026, RZLT trades at $3.94 with a market cap of $385.17M and a P/E ratio of -4.05. RZLT moved -1.50% today. Year to date, RZLT is +81.99%; over the trailing twelve months it is -55.28%. Its 52-week range spans $1.07 to $11.46. Analyst consensus is buy with an average price target of $5.50. Rallies surfaces RZLT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks RZLT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $3.94 |
| Market Cap | $385.17M |
| P/E Ratio | -4.05 |
| EPS | $-0.98 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.46 |
| 52-Week Low | $1.07 |
| Volume | 3.72M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-74.41M |
| Gross Margin | 0.00% |
2 analysts cover RZLT: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.50.